{"version":"1.0","type":"link","title":"Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC.","author_name":"Liu B 외","author_url":"https://prs-insight.online/author/Liu%20B","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/120404","thumbnail_width":1200,"thumbnail_height":630}